Cortisol's Role in Gluconeogenesis

Mechanism of Cortisol Action

Cortisol released during stress directly acts on the liver to stimulate endogenous glucose production through gluconeogenesis, as recommended by the American Society of Anesthesiologists 1, 2

During stress, the release of stress hormones, including cortisol, leads to peripheral insulin resistance and increased hepatic glucose production, according to the European Society of Anaesthesiology 3, 4
Cortisol specifically increases hepatic glycogen supply and stimulates neoglucogenesis in the liver, contributing to stress hyperglycemia, with a moderate level of evidence 1
The stimulation of endogenous glucose production by cortisol in the liver is a key mechanism of stress hyperglycemia, with a high level of evidence 5

The cortisol-mediated increase in hepatic gluconeogenesis contributes to stress hyperglycemia observed in critically ill patients and during surgical procedures, as stated by the European Society of Cardiology 6
Prolonged cortisol elevation can lead to persistent insulin resistance and hyperglycemia, affecting patient outcomes in critical illness, with a strong level of evidence 6
Understanding cortisol's effect on hepatic gluconeogenesis is important for managing stress-induced hyperglycemia in clinical settings, according to the American Society of Anesthesiologists 4

Cortisol released during stress acts specifically on hepatic tissues to upregulate both gluconeogenesis and glycogenolysis, even when serum insulin levels are high, as noted by the European Society of Cardiology 7

The stress imposed by critical illness triggers metabolic and endocrine abnormalities, with cortisol being one of the key hormones that stimulate hepatic glucose production, according to the European Society of Cardiology 8
Stress-induced cortisol release leads to peripheral insulin resistance and simultaneously increases hepatic glucose output, contributing to "stress diabetes" or "diabetes of injury", as reported by the European Society of Cardiology 7

The cortisol-mediated increase in hepatic glucose production contributes significantly to the hyperglycemia observed during physical and psychological stress, requiring appropriate management strategies, as suggested by the American Academy of Family Physicians and the European Society of Cardiology 9, 7

While cortisol is produced by the adrenal cortex, it does not primarily act on this structure to stimulate gluconeogenesis, but rather targets hepatic tissues, as noted by the American Heart Association 10, 11

During stress, cortisol release leads to peripheral insulin resistance and increased hepatic glucose production, creating a state of "stress hyperglycemia" in patients with elevated blood glucose levels 12

Excess cortisol exposure causes hyperglycemia and insulin resistance that can lead to diabetes in individuals with Cushing's syndrome 13
The American Diabetes Association notes that excess glucocorticoids can precipitate diabetes in individuals with preexisting insulin resistance 13

The American Diabetes Association states that thyroxine does not primarily cause insulin resistance in tissues, unlike cortisol 14
The American Diabetes Association also notes that glucagon primarily increases blood glucose through glycogenolysis and gluconeogenesis but doesn't significantly increase insulin resistance 14
Growth hormone can antagonize insulin action, but its effect on insulin resistance is less pronounced than cortisol, according to the American Diabetes Association 13

Normal blood glucose values don't always indicate normal metabolism, as counter-regulatory hormones like cortisol can be actively working to maintain euglycemia despite underlying metabolic disturbances, as reported by the Endocrine Society 15
The Endocrine Society also notes that the same euglycemic state can disguise very different counter-regulatory hormonal activities and significantly different biochemical states of cellular metabolism 15
Prolonged hyperglycemia itself can induce insulin resistance, creating a vicious cycle that further worsens glucose control in patients with diabetes, according to the American Diabetes Association 16

Sustained high-normal cortisol creates a state of chronic mild hyperglycemia that will progressively elevate HbA1c over the 8-12 week measurement window, as recommended by the American Diabetes Association 17

Cortisol-induced insulin resistance affects lipid metabolism by increasing the release of free fatty acids from peripheral tissues, which can lead to the development of metabolic syndrome, according to the American Heart Association 17, 18, 19

Measure HbA1c rather than relying on fasting glucose alone, as HbA1c reflects integrated glucose control over 8-12 weeks and will capture the chronic effects of elevated cortisol, as suggested by the Endocrine Society 17